Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L19 pseudogene 15 (RPL19P15; ENSG00000232172) is a nonfunctional copy of the ribosomal protein L19 gene. Pseudogenes like RPL19P15 do not encode functional proteins and are not considered biochemical or therapeutic targets[3][5]. They are generally classified as genomic relics with no established biological function, clinical relevance, or pharmacological utility.\n\nIf you intended to refer to the active, protein-coding ribosomal protein L19 (RPL19), that gene is involved in ribosome assembly and various cancer-related pathways, but "RPL19 pseudogene" denotes only the non-functional, non-transcribed locus[1][2][4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L19 pseudogene 15 (RPL19P15).